How do I Diagnose and Manage Catheter-Related Blood Stream Infections?

Evidence-Based Practice of Critical Care

Volumn , Issue , 2011, Pages 263-270

  McKenny, Michael ^a   Fitzgerald, Marianne ^a   Scully, Michael ^b  

^a OUR LADY OF LOURDES HOSPITAL   (Ireland)

^b Intensive Care Medicine   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882871251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5476-4.00039-0     Document Type: Chapter

References (57)

1. Byrnes M.C., Coopersmith C.M. Prevention of catheter related blood stream infection. Curr Opin Crit Care 2007, 13:411-415.
2. O'Grady N.P., Alexander M., Dellinger E.P. Guidelines for the prevention of intravascular catheter related infections. Clin Infect Dis 2002, 35:1281-1307.
3. Wenzel R.P., Edmond M.B. Team-based prevention of catheter related infections. N Engl J Med 2006, 355:2781-2783.
4. National Nosocomial Infections Surveillance (NNIS) system report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32:470-485.
5. Mermel L.A., Eggimann P., Harbarth S., et al. Prevention of intravascular catheter-related infections. Ann Intern Med 2000, 132:391-402.
6. Blot S.I., Depuydt P., Annemans L., et al. Clinical and economic outcome in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005, 41:1591-1598.
7. Digiovine B., Chenoweth C., Watts C., Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999, 160:976-981.
8. Diekema D.J., Beekmann S.E., Chapin K.C., et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003, 41:3655-3660.
9. Freid V.M., Prager K., MacKay A.P., Xia H. Health, United States, 2003 2003, National Center for Health Statistics, Hyattsville, MD.
10. National Nosocomial Infections Surveillance (NNIS) system report. Data summary from January 1992 to April 2000, issued June 2000. Am J Infect Control 2000, 28:429-448.
11. Warren D.K., Quadir W.W., Hollenbeak C.S., et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a non-teaching hospital. Crit Care Med 2006, 34:2084-2089.
12. Mermel L.A., Farr B.M., Sherertz R.J. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001, 32:1249-1272.
13. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: A systematic review of 200 published prospective studies. Mayo Clin Proc 2006, 81:1159-1171.
14. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
15. Hidron A.I., Edwards J.R., Patel J., et al. NHSN annual update. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:1096-11011.
16. Leroy O., Gangeux J.P., Montravers P., et al. Epidemiology, management and risk factors for death of invasive candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009, 37(5):1612-1618.
17. Marschall J., Mermel L.A., Classen D., et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(suppl 1):S22-S30.
18. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: Advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7:645-657.
19. Safdar N., Fine J.P., Maki D.G. Meta-analysis: Methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005, 142:451-466.
20. Safdar N., Maki D.G. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 2002, 30:2632-2635.
21. Walshe L.J., Malak S.F., Eagan J., Sepkowitz K.A. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 2002, 20:3276-3281.
22. Blot F., Nitenberg G., Brun-Buisson C. New tools in diagnosing catheter-related infections. Support Care Cancer 2000, 8:287-292.
23. Mermel L.A., Maki D.G. Detection of bacteremia in adults: Consequences of culturing an inadequate volume of blood. Ann Intern Med 1993, 119:270-272.
24. Ilstrup D.M., Washington J.A. The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis 1983, 1:107-110.
25. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.
26. Casey A.L., Mermel L.A., Nightingale P., Elliott T.S. Antimicrobial central venous catheters in adults: A systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776.
27. Jaeger K., Osthaus A., Heine J., et al. Efficacy of a benzalkonium chloride impregnated central venous catheter to prevent catheter associated infection in cancer patients. Chemotherapy 2001, 47:50-55.
28. Yücel N., Lefering R., Maegele M., et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: A randomized controlled clinical trial. J Antimicrob Chemother 2004, 54:1109-1115.
29. Hanna H., Benjamin R., Chatzinikolau I., et al. Long term silicone central venous catheters impregnated with minocycline and rifampicin decrease rates of catheter related bloodstream infection in cancer patients, a prospective randomized clinical trial. J Clin Oncol 2004, 22:3163-3171.
30. Hockenhull J.C., Dwan K., Boland A., et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: A systematic review and economic evaluation. Health Technol Assess 2008, 12:iii-iv. xi-xii 1-154.
31. Niel-Weise B.S., Stijnen T., van den Broek Anti-infective-treated central venous catheters: A systematic review of randomized controlled trials. Intensive Care Med 2007, 33:2058-2068.
32. Schierholz J.M., Fleck C., Beuth J., Pulverer G. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. Antimicrob Chemother 2000, 46:45-50.
33. Sampath L.A., Tambe S.M., Modak S.M. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: Evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001, 22:640-666.
34. Chatzinikolaou I., Hanna H., Graviss L., et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: Efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003, 24:961-963.
35. Tambe S.M., Sampath L., Modak S.M. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001, 47:589-598.
36. León C., Ruiz-Santana S., Rello J., et al. Benefits of minocycline and rifampin-impregnated central venous catheters: A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004, 30:1891-1899.
37. Goetz A.M., Wagener M.M., Miller J.M., Muder R.R. Risk of infection due to central venous catheters: Effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998, 19:842-845.
38. Safdar N., Kluger D.M., Maki D.G. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: Implications for preventive strategies. Medicine 2002, 81:466-479.
39. Lorente L., Henry C., Martin M., et al. Central venous catheter related infection in a prospective and observational study of 2595 catheters. Crit Care 2005, 9:R631-R635.
40. Deshpande K.S., Hatem C., Ulrich H.L., et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005, 33:13-20.
41. Gowardman J.R., Robertson I.K., Parkes S., Rickard C.M. Influence of insertion site on central venous catheter colonization and bloodstream infections. Intensive Care Med 2008, 34:1038-1045.
42. Cobb D.K., High K.P., Sawyer R.G., et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992, 327:1062-1068.
43. Castelli G.P., Pognani C., Stuani A., et al. Central venous catheter replacement in the ICU: New site versus guidewire exchange. Minerva Anestesiol 2007, 73:267-273.
44. Cook D., Randolph A., Kernerman P., et al. Central venous catheter replacement strategies: A systematic review of the literature. Crit Care Med 1997, 25:1417-1424.
45. Badley A.D., Stecelberg J.M., Wollan P.C., Thompson R.L. Infectious rates of central venous pressure catheters: Comparison between newly placed catheters and those that have been changed. Mayo Clin Proc 1996, 71:836-846.
46. Gillies D., O'Riordan L., Wallen M., et al. Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev 2005, CD003588.
47. Kemp L., Burge J., Choban P., et al. The effect of catheter type and site on infection rates in total parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1994, 18:71-144.
48. Ishizuka M., Nagata H., Takagi K., Kubota K. Femoral venous catheterization is a major risk factor for central venous catheter-related bloodstream infection. J Invest Surg 2009, 22:16-21.
49. Dimick J.B., Swoboda S., Talamini M.A., et al. Risk of colonization of central venous catheters: Catheters for total parenteral nutrition vs other catheters. Am J Crit Care 2003, 12:228-335.
50. Shapiro J.M., Bond E.L., Garman J.K. Use of a chlorhexidine dressing to reduce microbial colonization of epidural catheters. Anesthesiology 1990, 73:625-631.
51. Hanazaki K., Shingu K., Adachi W., et al. Chlorhexidine dressing for reduction in microbial colonization of the skin with central venous catheters: A prospective randomized controlled trial. J Hosp Infect 1999, 42:165-168.
52. Garland J.S., Alex C.P., Mueller C.D., et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001, 107:1431-1436.
53. Levy I., Katz J., Solter E., et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: A randomized controlled study. Pediatr Infect Dis J 2005, 24:676-679.
54. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
55. Blot S., Cankurtaran M., Petrovic M., et al. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: A comparison between middle-aged, old and very old patients. Crit Care Med 2009, 37:1634-1641.
56. Simon A., Bode U., Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: An update. Clin Microbiol Infect 2006, 12:606-620.
57. Viale P., Pagani L., Petrosillo N., et al. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother 2003, 15:152-156.